Fuji Pharma Management
Management criteria checks 2/4
Fuji Pharma's CEO is Shuhei Morita, appointed in Oct 2024, has a tenure of less than a year. directly owns 0.016% of the company’s shares, worth €35.01K. The average tenure of the management team and the board of directors is 7.3 years and 4.7 years respectively.
Key information
Shuhei Morita
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.02% |
| Management average tenure | 7.3yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
CEO
Shuhei Morita (50 yo)
less than a year
Tenure
Shuhei Morita serves as President & CEO of Fuji Pharma Co., Ltd. from October 2024. Shuhei Morita is Director of Fuji Pharma Co., Ltd.from December 2023. Shuhei Morita joined the Fuji Pharma Co., Ltd. in...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | 0.016% € 35.0k | |
| VP, Executive Officer & Director | 3.3yrs | no data | 0.084% € 188.5k | |
| Managing Executive Officer & Corporate Planning Department | 17.3yrs | no data | no data | |
| Managing Executive Officer & GM of Corporate Division | 8.3yrs | no data | no data | |
| Managing Executive Officer & Head of Research and Development | no data | no data | no data | |
| Executive Office & | no data | no data | no data | |
| Executive Officer & Head of Quality Assurance Department | no data | no data | no data | |
| Executive Officer & Head of Injection Manufacturing Department | no data | no data | no data | |
| Managing Executive Officer | no data | no data | no data | |
| Executive VP | 7.3yrs | no data | 0.0035% € 7.9k | |
| Managing Executive Officer & SCM Manager | no data | no data | no data |
7.3yrs
Average Tenure
59yo
Average Age
Experienced Management: FUP's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | no data | 0.016% € 35.0k | |
| VP, Executive Officer & Director | 7.2yrs | no data | 0.084% € 188.5k | |
| Executive VP | 2.2yrs | no data | 0.0035% € 7.9k | |
| Independent Outside Director | no data | no data | 0.010% € 23.1k | |
| Outside Audit & Supervisory Board Member | 21.2yrs | no data | 0.032% € 71.1k | |
| Independent Outside Director | 8.2yrs | no data | 0.025% € 55.4k | |
| Independent Outside Director | 7.2yrs | no data | 0.025% € 55.4k | |
| Representative Chairman | less than a year | no data | 0.053% € 118.8k | |
| Outside Audit & Supervisory Board Member | 5.2yrs | no data | 0.0058% € 12.9k | |
| Independent Outside Director | 4.2yrs | no data | 0.0053% € 12.0k | |
| Independent Outside Director | 4.2yrs | no data | 0.0025% € 5.5k | |
| Audit & Supervisory Board Chairman | no data | no data | 0.034% € 75.7k |
4.7yrs
Average Tenure
61.5yo
Average Age
Experienced Board: FUP's board of directors are considered experienced (4.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 14:55 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fuji Pharma Co., Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yoshinaga Toshiaki | Aizawa Securities Co. Ltd. |
| Masao Yoshida | Ichiyoshi Research Institute Inc. |
| Shigekazu Ishida | Marusan Securities Co. Ltd. |